Role of Her-2/neu Overexpression and Clinical Determinants of Early Mortality in Glioblastoma Multiforme.

MLA

Vijay Koka, et al. “Role of Her-2/Neu Overexpression and Clinical Determinants of Early Mortality in Glioblastoma Multiforme.” American Journal of Clinical Oncology, vol. 26, no. 4, Aug. 2003, pp. 332–35. EBSCOhost, https://doi.org/10.1097/01.coc.0000020922.66984.e7.

APA

Vijay Koka, Anil Potti, Scott E. Forseen, Hassan Pervez, Genise N. Fraiman, Michael Koch, & Ralph Levitt. (2003). Role of Her-2/neu Overexpression and Clinical Determinants of Early Mortality in Glioblastoma Multiforme. American Journal of Clinical Oncology, 26(4), 332–335. https://doi.org/10.1097/01.coc.0000020922.66984.e7

Chicago

Vijay Koka, Anil Potti, Scott E. Forseen, Hassan Pervez, Genise N. Fraiman, Michael Koch, and Ralph Levitt. 2003. “Role of Her-2/Neu Overexpression and Clinical Determinants of Early Mortality in Glioblastoma Multiforme.” American Journal of Clinical Oncology 26 (4): 332–35. doi:10.1097/01.coc.0000020922.66984.e7.